Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Illumina's TruSight One Panel

Premium

Illumina has launched its TruSight One sequencing panel, which targets 4,813 genes with known associated clinical phenotypes. The panel is designed to be used in conjunction with Illumina's VariantStudio analysis and reporting software, which will also include new features that expand annotation capabilities such as support to enable family-based filtering, variant classification, and the ability to generate ready-to-use reports.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.